Abstract:
Novel compounds which are 2,6-methano-2H-1-benzoxocincarboxamides having 5-HT3-antagonist properties including unique CNS, anti-emetic and gastric prokinetic activities and which are void of any significant D2 receptor binding affinity, processes for their preparation, therapeutic compositions and methods of treatment of disorders which result from 5-HT3 activity using said compounds are disclosed.
Abstract:
Die vorliegende Erfindung betrifft die Verbesserung organischer Elektrolumineszenzvorrichtungen, insbesondere blau emittierender Vorrichtungen, indem Verbindungen gemäß Formel (1) als Dotanden in der emittierenden Schicht verwendet werden.
Abstract:
The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula (I) wherein: R?1¿ is a 5- to 6-membered ring group which may be substituted; X?1¿ is a bond or the like; ring A is a 5- to 6-membered ring group which may be substituted; ring B is a 8- to 10-membered ring group which may be substituted; X?2¿ is a bivalent group of 1 to 4 atoms; Z?1¿ is a bivalent cyclic ring group or the like; Z?2¿ is a bond or the like; and R?2¿ is an amino group, a nitrogen-containing heterocyclic group which may be substituted or the like, or a salt thereof.
Abstract translation:本发明提供具有CCR拮抗剂活性,特别是CCR5拮抗剂活性的新的环状化合物及其用途。 本发明的化合物由式(I)表示,其中:R 1是可被取代的5至6元环基; X 1是键或类似物; 环A是可以被取代的5至6元环基团; 环B是可以被取代的8至10元环基团; X 2是1至4个原子的二价基团; Z 1是二价环状环基等; Z 2是键或类似物; R 2是氨基,可以被取代的含氮杂环基等,或其盐。
Abstract:
Compounds of formula (I), wherein Q, X, R?1, R2, R9¿ and Z are as defined in the text, including compositions containing said compounds and a method for using them to control arthropods.